Clinical trial
Efficacy of the Nanodropper Device on Pupillary Dilation
NCT05274321 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the Nanodropper Device on Pupillary Dilation
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 29, 2021
- Completion date
- November 19, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dilation